Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06428955 · ClinicalTrials.gov registry record · Phase 4
Evaluation of a Monofocal Intraocular Lens
A Phase 4 study of Cataract, sponsored by Carl Zeiss Meditec.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 44
- Enrollment target
- 4
- Study locations
NCT06428955 is a Phase 4 study of Cataract that is actively recruiting participants, run by Carl Zeiss Meditec. The registered enrollment target is 44 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (81% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT06428955, a Phase 4 study of Cataract, is actively recruiting participants, sponsored by Carl Zeiss Meditec.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 44 participants
- Enrollment target
- 4
- Study locations
Study Summary
The aim of this study is to investigate the 3-month visual performance of the CT LUCIA 621P IOL, a hydrophobic aspheric monofocal IOL with a non-constant aspheric optic profile in adult patients 50 years of age or older who are undergoing cataract surgery.
Conditions Studied
Interventions
- DEVICE CT LUCIA 621P
Study Locations (4)
Indiana
- Price Vision Group - Indianapolis
Kentucky
- Huffman & Huffman PSC - Lexington
Pennsylvania
- The Pennsylvania State University and Penn State Health - Hershey
Alcaldia Coyoacan
- Asociación Para Evitar La Ceguera en México, I.A.P. - Mexico City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2024-06-06 |
| Est. Completion | 2024-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06428955
The ClinicalTrials.gov registry entry for NCT06428955 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (81% lower). The listed sponsor is Carl Zeiss Meditec, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which CT LUCIA 621P is the first listed.
NCT06428955 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Indiana, Kentucky, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06428955 about?
NCT06428955 is a clinical study titled "Evaluation of a Monofocal Intraocular Lens". The aim of this study is to investigate the 3-month visual performance of the CT LUCIA 621P IOL, a hydrophobic aspheric monofocal IOL with a non-constant aspheric optic profile in adult patients 50 years of age or older who are undergoing cataract surgery.
What is the current status of trial NCT06428955?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 44 participants. The study started on 2024-06-06. Estimated completion is 2024-12.
What conditions does trial NCT06428955 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT06428955?
The interventions under investigation include: CT LUCIA 621P (DEVICE).
Who is sponsoring clinical trial NCT06428955?
This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06428955 being conducted?
This trial has 4 study locations across Indiana, Kentucky, Pennsylvania, Alcaldia Coyoacan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
RECRUITING · Phase 4
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Dropless vs. Standard Drops Contralateral Eye Study
COMPLETED · Phase 4
-
Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.